Cell and Gene Therapies

Advanced Therapies (or Regenerative Medicines) including cell, gene and tissue engineered products are an emerging class of living medicines. Despite their curative potential – they are currently prohibitively expensive to patients, labour intensive to produce and complex to develop. To move these therapies into mainstream usage the field is turning to technology.

CGT.jpg

Challenges in Cell and Gene Therapy

The Synthace Solution

 
Petri Dish.png

Improve Product Quality and Quantity

Autologous cell therapy products are made on a patient-to-patient basis, with methods often developed on healthy donor material. A deep understanding of production parameters methods is needed to define representative critical quality attributes (CQAs) and create robust scaled-out processes.

Controls.png

Automated DoE allows full exploration of process and product parameters.

Our platform dramatically reduces the planning and execution time of complex, multi-factorial experiments, making insight-rich experiments such as DOE routine. Digitally defined methods also accelerate and standardise tech transfer from process dev to manufacturing and from biotech company to CDMO.

 
Coins.png

Reduce Cost

87% of CGT companies think reducing the high CoGs is important. Reducing the labour investment into many manual processes such as QC is essential for increasing facility usage, reducing human error and thus reducing cost

 

 

Speedometer.png

Automation allows for 24/7, 365 facility operation.

 Liquid handling automation, coupled enhanced sample traceability and analytics integration closes the loop, reducing human intervention and increasing throughput.

 
DNA.png

Tools are needed that enable a data science approach to process optimisation and manufacturing.

To robustly and cost-effectively scale-up or scale-out CGT products requires a deeper understanding of the experimental design space, as well as use of technologies that can adapt to manufacturing variances in real-time.

Connected Points.png

Automated experimentation enables machine learning. 

Process development methods such as PAT (process analytical technology) and DOE are routinely used in CMC and manufacturing, but both generate huge data streams. Our platform works with existing hardware to produce structured data sets; enabling machine learning for advanced process optimisation or adaptive manufacturing.

 
 

Suggested applications in Cell and Gene Therapy

 

  • Optimisation of growth media to increase AAV or lentiviral titre

  • qPCR automation for higher throughput QC testing in autologous cell therapy

  • Transfection and transduction protocol refinement

  • Media optimisation for cell expansion and differentiation

  • Rapid in-house DNA assembly to create CAR libraries

 
CGT right.jpg

Ready to Revolutionise your Workflow?

Book a Demo